X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4743) 4743
Newsletter (711) 711
Publication (275) 275
Newspaper Article (82) 82
Magazine Article (69) 69
Book Review (67) 67
Book Chapter (35) 35
Trade Publication Article (21) 21
Dissertation (10) 10
Conference Proceeding (7) 7
Web Resource (4) 4
Government Document (3) 3
Transcript (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
finasteride (4247) 4247
male (2817) 2817
humans (2716) 2716
index medicus (1208) 1208
finasteride - therapeutic use (1159) 1159
urology & nephrology (1098) 1098
middle aged (1049) 1049
men (937) 937
aged (921) 921
prostatic hyperplasia - drug therapy (890) 890
benign prostatic hyperplasia (819) 819
prostate cancer (805) 805
animals (729) 729
cancer (683) 683
research (665) 665
prostate (664) 664
enzyme inhibitors - therapeutic use (637) 637
5-alpha reductase inhibitors (633) 633
dutasteride (596) 596
testosterone (577) 577
finasteride - pharmacology (562) 562
female (546) 546
adult (520) 520
care and treatment (442) 442
treatment outcome (438) 438
hyperplasia (432) 432
antiandrogens (426) 426
pharmacology & pharmacy (426) 426
rats (413) 413
hypertrophy (404) 404
prevention (404) 404
endocrinology & metabolism (364) 364
alopecia (363) 363
analysis (361) 361
dihydrotestosterone (360) 360
prostatic neoplasms - prevention & control (339) 339
finasteride - adverse effects (331) 331
alopecia - drug therapy (327) 327
baldness (327) 327
dermatology (327) 327
efficacy (327) 327
aged, 80 and over (323) 323
androgenetic alopecia (318) 318
risk factors (318) 318
finasteride - administration & dosage (312) 312
enzyme inhibitors - pharmacology (304) 304
prostate-specific antigen - blood (292) 292
drugs (291) 291
adrenergic alpha-antagonists - therapeutic use (290) 290
oncology (285) 285
prostatic hyperplasia - complications (281) 281
risk (281) 281
androgens (278) 278
5-alpha reductase inhibitors - therapeutic use (276) 276
prostate - pathology (273) 273
medicine, general & internal (271) 271
drug therapy (269) 269
therapy (266) 266
health aspects (250) 250
double-blind method (248) 248
prostatic hyperplasia - pathology (245) 245
urology (245) 245
reports (243) 243
prostatic neoplasms - pathology (242) 242
drug therapy, combination (241) 241
prostate - drug effects (240) 240
oncology, experimental (234) 234
azasteroids - therapeutic use (233) 233
5-alpha-reductase inhibitor (227) 227
urinary-tract symptoms (213) 213
expression (207) 207
prostatic neoplasms - drug therapy (206) 206
time factors (198) 198
androgen antagonists - therapeutic use (197) 197
universities and colleges (194) 194
doxazosin (192) 192
steroid 5-alpha-reductase (192) 192
dose-response relationship, drug (183) 183
mice (183) 183
combination therapy (178) 178
bph (176) 176
diagnosis (174) 174
prospective studies (170) 170
prostate-specific antigen (168) 168
randomized controlled trials as topic (168) 168
tamsulosin (168) 168
testosterone - blood (168) 168
surgery (166) 166
women (162) 162
prostatic hyperplasia - therapy (161) 161
rats, sprague-dawley (161) 161
growth (160) 160
chemoprevention (157) 157
double-blind (156) 156
prostatic hyperplasia (156) 156
prostatic hyperplasia - diagnosis (154) 154
5-alpha-reductase (151) 151
rat (151) 151
prostatic hyperplasia - surgery (150) 150
antigen (149) 149
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5246) 5246
German (112) 112
French (80) 80
Spanish (50) 50
Korean (27) 27
Italian (26) 26
Russian (24) 24
Chinese (21) 21
Japanese (14) 14
Polish (12) 12
Portuguese (9) 9
Turkish (5) 5
Hungarian (4) 4
Bulgarian (3) 3
Czech (3) 3
Danish (3) 3
Finnish (3) 3
Croatian (2) 2
Dutch (2) 2
Norwegian (2) 2
Swedish (2) 2
Greek (1) 1
Hebrew (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Der Urologe A, ISSN 0340-2592, 03/2013, Volume 52, Issue 3, p. 354
Die intraprostatische Injektionstherapie stellt ein minimal-invasives Verfahren zur Behandlung des benignen Prostatasyndroms (BPS) dar und konnte bei zunehmend... 
Finasteride
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 07/2019, Volume 111, Issue 7, pp. 747 - 747
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 06/2018, Volume 45, Issue S19, pp. 377 - 377
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 74, Issue 5, pp. AB138 - AB138
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 74, Issue 5, pp. AB37 - AB37
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 09/2018, Volume 179, Issue 3, pp. 785 - 786
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 2009, Volume 36, Issue 4, pp. 433 - 443
The aim of this study was to investigate what the consequences of induced drug metabolism, caused by St. John's wort (SJW, ) treatment, would have on the... 
Hypericum perforatum | Biliary excretion | Herb–drug interactions | Finasteride | Finasteride-ω-oic acid (Carboxy-finasteride) | Human volunteers | Herb-drug interactions | HYPERICUM-PERFORATUM | PREGNANE X-RECEPTOR | JEJUNAL PERFUSION | 5-ALPHA-REDUCTASE INHIBITOR | Carboxy-finasteride | ULTRAVIOLET DETECTION | OXIDATIVE-METABOLISM | Finasteride-omega-oic acid | BENIGN PROSTATIC HYPERPLASIA | PERFORMANCE LIQUID-CHROMATOGRAPHY | ORAL BIOAVAILABILITY | PHARMACOLOGY & PHARMACY | DRUG-METABOLISM | Enzyme Inhibitors - blood | Finasteride - pharmacokinetics | Humans | Hypericum | Half-Life | Male | Reference Values | Terpenes - blood | Chromatography, High Pressure Liquid | Spectrophotometry, Ultraviolet | Phloroglucinol - blood | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Enzyme Inhibitors - pharmacokinetics | Biliary Tract - metabolism | Finasteride - blood | Bridged Bicyclo Compounds - blood | Adult | Enzyme Inhibitors - urine | Phloroglucinol - analogs & derivatives | Finasteride - urine | Medical equipment | Plasma physics | Metabolites | Analysis | Medicine, Botanic | Pharmacy | Physiological aspects | Antiandrogens | Medicine, Herbal | Physiological apparatus | Pharmaceutical Sciences | Basic Medicine | PHARMACY | Medical and Health Sciences | Medicin och hälsovetenskap | Farmaceutiska vetenskaper | Medicinska och farmaceutiska grundvetenskaper | FARMACI
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2018, Volume 110, Issue 11, pp. 1159 - 1160
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 08/2019, Volume 286, Issue 2, pp. 233 - 234
Click here to view the view the Letter by Dr. Mossman and Dr. Pacey 
MEDICINE, GENERAL & INTERNAL | FINASTERIDE
Journal Article
09/2013
Purpose: To study the effect of some factors on the size of finasteride nano-emulsion by chemometric approach which could predict the size of nano-emulsion... 
Finasteride | Nanoemulsion | Box-Behnken experimental design | Optimization
Web Resource
American Journal of Men's Health, ISSN 1557-9883, 1/2018, Volume 12, Issue 1, pp. 90 - 95
Androgenetic alopecia, the gradual, progressive loss of hair frequently results in psychological despair, in part related to changes in self-image. Current... 
finasteride | androgenetic alopecia | post-finasteride syndrome
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 10/2016, Volume 121, p. 737
In this study, we report the synthesis and anti-proliferative effect of a set of eight androst-4-ene-3-one derivatives with different arylcarbamoyl groups at... 
Testosterone | Finasteride | Flutamide | Ketoconazole
Journal Article
by Jin, S and Fan, D and Liu, Z and Sun, J and Xing, N and Niu, Y
European Urology Supplements, ISSN 1569-9056, 03/2016, Volume 15, Issue 3, p. e102
Journal Article
The Journal of Urology, ISSN 0022-5347, 01/2018, Volume 199, Issue 1, pp. 7 - 8
Journal Article
Physiology & Behavior, ISSN 0031-9384, 07/2018, Volume 191, p. 65
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.physbeh.2018.03.036 
Finasteride | Schizophrenia | Models | Clozapine | Suicide
Journal Article
10/2009
Background: Finasteride, a type P-selective 5a-reductase inhibitor, as a causative agent of decreasing dihydroxy testestrone (DHT) level, is effective in the... 
finasteride | topical gel | Androgenetic alopecia
Web Resource
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.